Health Condition 1: H521- Myopia Health Condition 2: H522- Astigmatism Health Condition 3: H520- Hypermetropia
Conditions
Interventions
Intervention1: Cyclopentolate: 1% Cyclopentolate eyedrops will be put in both eyes of the patient and mydriasis and cycloplegia done by the drug will be noted.
Control Intervention1: Tropicamide: 1% C
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Children aged 6 18 years Children willing to and able to attend three visits and No known allergy to tropicamide or cyclopentolate
Exclusion criteria
Exclusion criteria: 1. Children less than 6 years 2. Children are uncooperative for subjective acceptance 3. History of ocular surgery or trauma 4. Systemic illness requiring regular medication 5. Previous use of atropine or other cycloplegics in the past 3 months 6. Children with strabismus or nystagmus 7. Children with any neurological disorder 8. History of any drug use or ocular or systemic disorder that affects accommodation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Cycloplegic refractive error with 1% cyclopentolate 2.Cycloplegic refractive error with 1% tropicamide Timepoint: Group A initially receives cycloplegic refraction with 1% Cyclopentolate, followed by subjective acceptance testing after one week. After a washout period of one week, the same group undergoes cycloplegic refraction with 1% Tropicamide, followed again by subjective acceptance testing and vice versa for group B. | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjectively accepted spherical equivalent with 1% cyclopentolate versus 1% tropicamideTimepoint: follow up 1 week later | — |
Countries
India
Contacts
Public ContactShoubhik Chakraborty
KALINGA INSTITUTE OF MEDICAL SCIENCES , BHUBANESWAR
Outcome results
None listed